MedPath

ongterm effects of severe infections and sepsis.

Conditions
infection, sepsis, mitochondrial dysfunction
Registration Number
NL-OMON21743
Lead Sponsor
niversity Medical Center Groningen
Brief Summary

https://www.ncbi.nlm.nih.gov/pubmed/29905628

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

Adult patients, aged between 18 and 85 years

-Able to provide (deferred) informed consent themselves or informed consent can be obtained via next of kin or legal guardian

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:
- Discharged home without hospital admittance after ED visit
- Congenital mitochondrial diseases
- Renal transplant recipients
- Hepatic failure (Child Pugh C)
- Hepatorenal syndrome
- Start of antibiotics before blood sampling

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary objective of the current project is to study the association between biomarkers for renal mitochondrial damage in sepsis with the change in renal function and mortality after sepsis.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath